Evidence map›Paper›PMID 38974971›Full record

ArticleiScience2024

The virtual multiple sclerosis patient.

P Sorrentino, A Pathak, A Ziaeemehr, E Troisi Lopez, L Cipriano, A Romano, M Sparaco, M Quarantelli, A Banerjee, G Sorrentino and 2 more

Abstract read
In one paragraph

Article in iScience, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. The neurotoxic legacy of CAR-T cells: where do we stand?Therapeutic advances in neurological disorders · 2026
    Review
  5. Article
  6. Article
  7. Dynamic causal modelling in probabilistic programming languages.Journal of the Royal Society, Interface · 2025
    Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

P SorrentinoInstitut de Neurosciences des Systèmes, Aix-Marseille Université, Marseille, France.
A PathakNational Brain Research Centre, Manesar, Gurgaon, Haryana, India.
A ZiaeemehrInstitut de Neurosciences des Systèmes, Aix-Marseille Université, Marseille, France.
E Troisi LopezDepartment of Motor Sciences and Wellness, Parthenope University of Naples, Naples, Italy.
L CiprianoDepartment of Motor Sciences and Wellness, Parthenope University of Naples, Naples, Italy.
A RomanoDepartment of Motor Sciences and Wellness, Parthenope University of Naples, Naples, Italy.
M SparacoDepartment of Advanced Medical and Surgical Sciences, University of Campania Luigi Vanvitelli, Caserta, Italy.
M QuarantelliBiostructure and Bioimaging Institute, National Research Council, Naples, Italy.
A BanerjeeNational Brain Research Centre, Manesar, Gurgaon, Haryana, India.
G SorrentinoDepartment of Motor Sciences and Wellness, Parthenope University of Naples, Naples, Italy.
V JirsaInstitut de Neurosciences des Systèmes, Aix-Marseille Université, Marseille, France.
M HashemiInstitut de Neurosciences des Systèmes, Aix-Marseille Université, Marseille, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Multiple sclerosis (MS) diagnosis typically involves assessing clinical symptoms, MRI findings, and ruling out alternative explanations. While myelin damage broadly affects conduction speeds, traditional tests focus on specific white-matter tracts, which may not reflect overall impairment accurately. In this study, we integrate diffusion tensor immaging (DTI) and magnetoencephalography (MEG) data into individualized virtual brain models to estimate conduction velocities for MS patients and controls. Using Bayesian inference, we demonstrated a causal link between empirical spectral changes and inferred slower conduction velocities in patients. Remarkably, these velocities proved superior predictors of clinical disability compared to structural damage. Our findings underscore a nuanced relationship between conduction delays and large-scale brain dynamics, suggesting that individualized velocity alterations at the whole-brain level contribute causatively to clinical outcomes in MS.

Indexed as

health sciencesneuroscience

Identifiers

PMID38974971
PMCPMC11226980

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.